U
FMS.PR

UBS’s FRESENIUS MEDICAL CARE AG & CO KGAA ADS EA REPTG 1/2 PFD SH FMS.PR Stock Holding History

UBS’s Portfolio FMS.PR Stock Details FMS.PR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,868
Closed -$64K – 11256
2013
Q2 		$64K Buy
+1,868
New +$63.5K ﹤0.01% 6440

UBS's FMS.PR Position: Q3 2013 in Review

UBS sold out of FRESENIUS MEDICAL CARE AG & CO KGAA ADS EA REPTG 1/2 PFD SH (FMS.PR) in Q3 2013, closing a stake of 1,868 shares — an estimated $64K sold.

UBS first reported a position in FMS.PR in Q2 2013 and held it in 1 quarter. The position peaked at $64K in Q2 2013. 0 funds tracked by Wall St. Rank hold FMS.PR as of Q3 2013.

  • UBS reported no remaining FRESENIUS MEDICAL CARE AG & CO KGAA ADS EA REPTG 1/2 PFD SH position as of Q3 2013 after selling out during the quarter.
  • UBS sold 1,868 FRESENIUS MEDICAL CARE AG & CO KGAA ADS EA REPTG 1/2 PFD SH shares in Q3 2013, an estimated $64K.
  • UBS first reported a position in FRESENIUS MEDICAL CARE AG & CO KGAA ADS EA REPTG 1/2 PFD SH in Q2 2013 and held it in 1 quarter.
  • UBS's FRESENIUS MEDICAL CARE AG & CO KGAA ADS EA REPTG 1/2 PFD SH position peaked at $64K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held FRESENIUS MEDICAL CARE AG & CO KGAA ADS EA REPTG 1/2 PFD SH as of Q3 2013.

Based on UBS's 13F filing for Q3 2013, filed 13 Nov 2013.